SEC Tracker
Get the app

Oruka Therapeutics ORKA

Paul T Quinlan (General Counsel) sold 9,000 ORKA at $78.53, worth $707K

Form
4
Filed
Importance
Routine
  1. Paul Quinlan sold 9,000 shares at $7.80.
  2. Multiple sales occurred on Oct 20, 2026 with prices ranging from $74.47 to $79.72.
  3. A warrant for 9,000 shares was exercised.
  4. The sales were part of a pre-planned trading plan.

Written from the Form 4 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Oruka Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. CytomX Therapeutics CTMX public float $372M, Jun 30, 2025
  2. Cronos Group CRON public float $380M, Jun 30, 2025
  3. REGENXBIO RGNX public float $385M, Jun 30, 2025
  4. Capricor Therapeutics CAPR public float $399M, Jun 30, 2025
  5. Cryoport CYRX public float $400M, Jun 30, 2025